Its FDA-approved use is for type 2 diabetes only
Others find it helpful to think about what their body is capable of in the present, not how it appears
In 1980, the intestinal glucagon-like material, glicentin, was identified along with a smaller species named oxyntomodulin in 1982
[] It could be reasonable to start educating patients about to start on semaglutide on the risk of hyposalivation and the need for close follow up with their dentists for early detection and management
Routine cost savings or patient preference does not qualify
BEVERLY HILLS, CA / ACCESS Newswire / June 18, 2026 / Quick heads-up before you dive in: this is sponsored, affiliate content made for consumer education, not an independent clinical review - and if you buy through a link here, a commission may be earned at no extra cost to you